Abstract Background Direct-acting antivirals (DAAa) cure hepatitis C virus (HCV) infections
in 95% of infected patients. Modeling studies predict that universal HCV treatment will lead …

Abstract Background Modeling of the London hepatitis C virus (HCV) epidemic in men who
have sex with men (MSM) and are living with human immunodeficiency virus (HIV) …

Background Direct-acting antivirals (DAA) as curative therapy for hepatitis C virus (HCV)
infection offer> 95% sustained virologic response (SVR), including in patients with human …

Background Direct acting antivirals (DAA s) have revolutionized hepatitis C (HCV) treatment
with> 90% cure rates even in real‐world studies, giving hope that HCV can be eliminated …

Abstract Background The Netherlands has provided unrestricted access to direct-acting
antivirals (DAAs) since November 2015. We analyzed the nationwide hepatitis C virus …

Background. We report on the hepatitis C virus (HCV) epidemic among human
immunodeficiency virus (HIV)-positive men who have sex with men (MSM) in the United …

Abstract Purpose of Review Highly effective, well-tolerated interferon-free direct-acting
antivirals (DAA) have revolutionised hepatitis C virus (HCV) therapeutics, with the …

Abstract Background In 2016, the World Health Organization (WHO) introduced global
targets for the elimination of hepatitis C virus (HCV) by 2030. We conducted a nationwide …

Summary Background In the Netherlands, access to direct-acting antivirals (DAAs) against
hepatitis C virus (HCV) has been unrestricted for chronic infection since 2015. We evaluated …

Background Treatment of hepatitis C virus infections (HCV) with direct acting antivirals
(DAA) can prevent new infections since cured individuals cannot transmit HCV. However, as …